Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDB-2914 versus levonorgestrel for emergency contraception within 120 hours
2006-003387-55Phase 3Completed
- Sponsor
- HRA Pharma
- Start
- Sep 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in None comparing Ulipristal acetate with Levonorgestrel (2 arms). Primary endpoints: Pregnancy rate after emergency contraception, Pregnancy rate versus expected rate without emergency contraception and 1 more. Started Sep 2007; status: completed.
02
Drugs
ulipristalavatrombopag
Beyond the preview
Go deeper on 2006-003387-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003387-55.